Here’s why I’d invest £1,000 in these two FTSE 100 stocks in a Stocks and Shares ISA today

These two FTSE 100 (INDEXFTSE:UKX) shares could offer impressive long-term returns in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The continued fall in the FTSE 100’s price level due to coronavirus fears could cause many investors to adopt a cautious attitude. After all, the stock market could decline further in the near term, which may make less risky assets such as cash and bonds appear to be more attractive.

However, the FTSE 100 contains a number of companies that offer defensive qualities. As such, they could offer superior performances relative to their index peers. Here are two such stocks that could deliver impressive total returns in the long run, as well as relatively low risks in the short term.

AstraZeneca

The AstraZeneca (LSE: AZN) share price has held up relatively well in recent weeks compared to the wider FTSE 100. Investors continue to be buoyed by the company’s improving financial performance over the past couple of years, with the business delivering bottom-line growth following a long period of decline.

Looking ahead, further earnings growth is forecast by the market. AstraZeneca is expected to post a rise in its bottom line of 25% next year, which could catalyse investor sentiment. It may also lead to a rising dividend, which may increase the income appeal of the stock while it has a dividend yield of 2.8% following its recent share price rise.

In addition, the pharmaceutical company’s financial performance may be less negatively impacted by market uncertainty. With investor sentiment having weakened in recent months as the threat of a slowdown in the world economy’s growth rate has increased due to the coronavirus, AstraZeneca’s defensive characteristics may increase its popularity among risk-averse investors.

As such, now could be the right time to buy the stock as it delivers improving financial performance despite a weakening global economic outlook.

Severn Trent

Another FTSE 100 company that appears to offer defensive characteristics is Severn Trent (LSE: SVT). The utility company’s outlook has improved over the past couple of months since the possibility of the sector being nationalised has declined considerably following the general election.

This could make investors more upbeat about the prospects for utility companies – especially since they have a solid track record of dividend growth and their business models are relatively immune to the prospects for the wider economy. Their increasing popularity among investors could catalyse their share prices over the medium term.

Since Severn Trent has a dividend yield of 3.8%, it seems to offer fair value for money. Certainly, there are risks ahead for the sector, such as from regulatory change. But with the UK economy facing an uncertain period due to Brexit, and the world economy’s growth rate having been negatively impacted by the coronavirus, the risk/reward ratio offered by Severn Trent could mean that now is the right time to buy a slice of it and hold it for the long run.

Peter Stephens owns shares of AstraZeneca. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature black woman at home texting on her cell phone while sitting on the couch
Investing Articles

Could this cheap FTSE 100 stock be the next Rolls-Royce?

Paul Summers casts his eye over a battered-but-high-quality FTSE 100 stock. Is this the next top-tier company to stage a…

Read more »

ISA Individual Savings Account
Investing Articles

Hesitant over a Stocks and Shares ISA? Here’s a way to deal with scary markets

Volatile stock markets are scaring potential investors away from getting started with their first Stocks and Shares ISA in 2026.

Read more »

This way, That way, The other way - pointing in different directions
Market Movers

Standard Life’s announced a £2bn deal but its share price is largely unchanged. Why?

James Beard considers why the Standard Life share price didn’t take off today (15 April) after the group announced it…

Read more »

Happy parents playing with little kids riding in box
Investing Articles

Up 12% in a month, Hollywood Bowl is a UK dividend stock on a roll

This 5%-yielding dividend stock was one of the top performers in the FTSE 250 index today. What sent it flying…

Read more »

Close-up of children holding a planet at the beach
Investing Articles

Young investors are taking the stock market on a rollercoaster ride. Here’s how retirees can buckle up

Mark Hartley reveals the volatile impact that younger investors are having on the stock market and how UK retirees can…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

£7,500 invested in Aviva shares 5 years ago is now worth…

A lump sum pumped into Aviva shares half a decade ago has grown a lot. Andrew Mackie looks at the…

Read more »

Young female hand showing five fingers.
Investing Articles

Could £20,000 invested in these 5 dividend shares produce £14,760 of passive income over the next 10 years?

James Beard considers the potential of dividend shares to deliver amazing levels of passive income. Here are five that have…

Read more »

Workers at Whiting refinery, US
Investing Articles

At 570p, is it too late to consider buying BP shares?

Since the end of February, when the conflict in the Middle East started, BP shares have soared nearly 20%. But…

Read more »